These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23281850)

  • 1. Proteoglycans and their roles in brain cancer.
    Wade A; Robinson AE; Engler JR; Petritsch C; James CD; Phillips JJ
    FEBS J; 2013 May; 280(10):2399-417. PubMed ID: 23281850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroitin Sulphate Proteoglycans in the Tumour Microenvironment.
    Mellai M; Casalone C; Corona C; Crociara P; Favole A; Cassoni P; Schiffer D; Boldorini R
    Adv Exp Med Biol; 2020; 1272():73-92. PubMed ID: 32845503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
    Phillips JJ; Huillard E; Robinson AE; Ward A; Lum DH; Polley MY; Rosen SD; Rowitch DH; Werb Z
    J Clin Invest; 2012 Mar; 122(3):911-22. PubMed ID: 22293178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
    Iozzo RV; Sanderson RD
    J Cell Mol Med; 2011 May; 15(5):1013-31. PubMed ID: 21155971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
    Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
    Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
    Schaefer L; Tredup C; Gubbiotti MA; Iozzo RV
    FEBS J; 2017 Jan; 284(1):10-26. PubMed ID: 27860287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring Sulfatase Expression and Invasion in Glioblastoma.
    Wade A; Engler JR; Tran VM; Phillips JJ
    Methods Mol Biol; 2022; 2303():415-425. PubMed ID: 34626397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic targets in the brain tumor microenvironment.
    Phillips JJ
    Oncotarget; 2012 May; 3(5):568-575. PubMed ID: 22643827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
    Kim Y; Kang H; Powathil G; Kim H; Trucu D; Lee W; Lawler S; Chaplain M
    PLoS One; 2018; 13(10):e0204865. PubMed ID: 30286133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.
    Neill T; Schaefer L; Iozzo RV
    Biochemistry; 2015 Aug; 54(30):4583-98. PubMed ID: 26177309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
    Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
    Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
    Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
    Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
    Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
    Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring sulfatase expression and invasion in glioblastoma.
    Wade A; Engler JR; Tran VM; Phillips JJ
    Methods Mol Biol; 2015; 1229():507-16. PubMed ID: 25325976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.
    Woerner BM; Luo J; Brown KR; Jackson E; Dahiya SM; Mischel P; Benovic JL; Piwnica-Worms D; Rubin JB
    Mol Cancer Res; 2012 Jan; 10(1):156-66. PubMed ID: 22086906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival.
    Kundu S; Xiong A; Spyrou A; Wicher G; Marinescu VD; Edqvist PD; Zhang L; Essand M; Dimberg A; Smits A; Ilan N; Vlodavsky I; Li JP; Forsberg-Nilsson K
    Mol Cancer Res; 2016 Dec; 14(12):1243-1253. PubMed ID: 27565180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
    Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
    Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.